Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
PZ HTL SA
GLOBETECH PUBLISHING LLC

Human Stem Cells Used to Generate Functional Kidney-Like Structures

By BiotechDaily International staff writers
Posted on 04 Dec 2013
Image: Salk Institute scientists have grown human stem cells into early-stage ureteric buds. They used mouse embryonic kidney cells (seen here in red) to coax the human stem cells to grow into the nascent mushroom-shaped buds (blue and green) (Photo courtesy of the Salk Institute for Biological Studies).
Image: Salk Institute scientists have grown human stem cells into early-stage ureteric buds. They used mouse embryonic kidney cells (seen here in red) to coax the human stem cells to grow into the nascent mushroom-shaped buds (blue and green) (Photo courtesy of the Salk Institute for Biological Studies).
A paper described the successful differentiation of human stem cells into functioning kidney-like structures.

The high incidence of kidney disease and the poor prognosis support the urgent need for the development of new therapeutic strategies.

Investigators at the Salk Institute for Biological Studies (La Jolla, CA, USA) described progress in the use of induced pluripotent stem cells (iPSCs) for kidney disease research in the November 17, 2013, online edition of the journal Nature Cell Biology.

They generated iPSCs from skin cells and then grew them in cultures laced with growth factors known to be linked to kidney development. The generated cells demonstrated rapid and specific expression of renal progenitor markers after four days of exposure to defined media conditions. Further maturation into ureteric bud structures was accomplished by employing a three-dimensional culture system in which the differentiated human cells assembled and integrated alongside mouse cells for the formation of chimeric ureteric buds. The ureteric bud is a protrusion from the mesonephric duct that appears during the development of the urinary and reproductive organs and eventually develops into the adult kidney.

“Attempts to differentiate human stem cells into renal cells have had limited success,” said senior author Dr. Juan Carlos Izpisua Belmonte, professor in the gene expression laboratory at the Salk Institute for Biological Studies. “We have developed a simple and efficient method that allows for the differentiation of human stem cells into well-organized three-D structures of the ureteric bud (UB), which later develops into the collecting duct system. Our results provide a new platform for the study of kidney diseases and lineage commitment, and open new avenues for the future application of regenerative strategies in the clinic.”

Related Links:

Salk Institute for Biological Studies



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Disruption and removal of malaria parasites by the experimental drug (+)-SJ733 (Photo courtesy of the University of California, San Francisco).

Experimental Antimalaria Drug Induces the Immune System to Destroy Infected Red Blood Cells

An experimental drug for the treatment of malaria was found to induce morphological changes in infected erythrocytes that enabled the immune system to recognize and eliminate them. Investigators at... Read more

Biochemistry

view channel

Blocking Enzyme Switch Turns Off Tumor Growth in T-Cell Acute Lymphoblastic Leukemia

Researchers recently reported that blocking the action of an enzyme “switch” needed to activate tumor growth is emerging as a practical strategy for treating T-cell acute lymphoblastic leukemia. An estimated 25% of the 500 US adolescents and young adults diagnosed yearly with this aggressive disease fail to respond to... Read more

Business

view channel

R&D Partnership Initiated to Reduce Development Time for New Drugs

nanoPET Pharma, GmbH (Berlin, Germany) signed an open-ended framework contract with the international pharmaceutical company Boehringer Ingelheim (Ridgefield, CT, USA). By developing customized contrast agents for research in both basic and preclinical studies, nanoPET Pharma will contribute to the enhancement of Boehringer... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.